[Low molecular weight heparins: mechanisms of action and pharmococynetics. Clinical advantages over the classic unfractioned heparins].
Low molecular weight heparins inaugurated a new era in the treatment and prevention of cardiovascular pathology. In this paper, a deep analysis of their mechanisms of action and pharmococynetics is made, and the advantages of its clinical utilization are emphasised, when compared to the classic unfractioned heparins.
Campos
Manuel
M
Serviço de Hematologia, Hospital de Santo António, Porto.
D000925:Anticoagulants / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy; D020246:Venous Thrombosis / Q000188:drug therapy
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight